Last reviewed · How we verify
DCC-2812
At a glance
| Generic name | DCC-2812 |
| Sponsor | Deciphera Pharmaceuticals, LLC |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
No approved indications tracked.
Common side effects
No common side effects on file.